宗旨和范围
Expert Opinion on Drug Delivery is a monthly peer-reviewed medical journal publishing review articles covering all aspects of research on drug delivery, from initial concept to potential therapeutic application and final relevance in clinical use. It was established in 2004 and is published by Taylor and Francis Group. The editor-in-chief is Uday Kompella (University of Colorado). Less
关键指标
期刊详情
- 出版商TAYLOR & FRANCIS LTD
- 出版语言English
- 出版频率Monthly
- 出版语言English
- 出版频率Monthly
- 创刊年份2004
- Publisher URL
- 网址
月数 | 发表论文百分比 |
---|---|
0-3 | 29% |
4-6 | 61% |
7-9 | 6% |
>9 | 4% |
Topics Covered
年度发行情况
- 5Y
- 10Y
常见问题
Expert Opinion on Drug Delivery 是从何时开始发行的?
Expert Opinion on Drug Delivery 自2004开始发行至今。
Expert Opinion on Drug Delivery 多久发行一次?
Expert Opinion on Drug Delivery 为Monthly。
Expert Opinion on Drug Delivery 的出版商是谁?
Expert Opinion on Drug Delivery 的出版商是TAYLOR & FRANCIS LTD。
我在哪里查看 Expert Opinion on Drug Delivery 的宗旨和范围?
查看 Expert Opinion on Drug Delivery 的宗旨和范围,请点击此处。
我如何在意得辑上查看Expert Opinion on Drug Delivery 的指标?
查看 Expert Opinion on Drug Delivery 的指标,请单击此处。
Expert Opinion on Drug Delivery 的 eISSN和pISSN 号分别是什么?
1744-7593 的 eISSN 为 1742-5247,pISSN 为 Expert Opinion on Drug Delivery 。
该期刊重点关注哪些主题?
本期刊关注的主题范围广泛,包括 Hepatocellular carcinoma, Drug delivery, Hyperthermia, Nanomaterials, Immunotherapy, Nutraceutical, Insulin pen, Chloroquine, Syringe, Bioavailability, Nanomedicine, Clinical investigation, Clinical trial, Nanocarriers, 3D printing, Follitropin alfa, Cystic fibrosis, Chitosan, Colorectal cancer, Type 2 diabetes。
为什么搜索适合我研究的期刊很重要?
选择与您研究领域紧密相关的期刊,有助于确保您的学术成果能够触及最合适的读者群体, 从而最大化您的学术影响力和对该领域的贡献。
对期刊的选择会影响我的学术事业吗?
当然。在知名期刊上发表论文可提升您的学术形象, 使您在获取资助、终身教职和其他职业机会方面更具竞争力。
只考虑具有高影响力的期刊是否明智?
虽然高影响力的期刊知名度高,但投稿竞争也相对激烈。因此, 关键在于权衡考虑期刊的影响因子与论文被接受的可能性。